Rare diseases
Investigational molecules
Locations
Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis
SpainA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
SpainA study of ACR-368 and gemcitabine for patients with endometrial cancer
SpainA Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer
SpainA study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer
SpainStudy of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
SpainA study of mRNA-4157 and a drug combination for patients with stage IV non-small cell lung cancer
SpainA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
SpainA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
SpainStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
SpainA study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer
SpainStudy of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
